Medicure (MCUJF) Income from Continuing Operations (2009 - 2026)
Medicure (MCUJF) recorded quarterly Income from Continuing Operations of 296057.51 in Q1 2026, up 95.72% quarter-over-quarter from 6923468.06 in Q4 2025, and up 38.79% on a YoY basis from 213316.21 in Q1 2025.
Medicure (MCUJF) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Medicure's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 296057.51 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 38.79% year-over-year to 296057.51; the TTM figure through Mar 2026 stood at 8801174.06 (down 686.67% YoY), while the FY2025 annual figure was 5089161.35, down 584.24% from the prior year.
- Income from Continuing Operations was 296057.51 for Q1 2026 at Medicure, up from 6923468.06 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3988509.72 in Q4 2022 to a low of 6923468.06 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 276958.15 across 5 years, with a median of 37847.77 in 2024.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 752.56% in 2024, then slumped 1648.95% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 3988509.72 in 2022, then tumbled by 130.02% to 1197292.91 in 2023, then jumped by 66.94% to 395864.57 in 2024, then plunged by 1648.95% to 6923468.06 in 2025, then jumped by 95.72% to 296057.51 in 2026.
- The last three Income from Continuing Operations figures came in at 296057.51 (Q1 2026), 6923468.06 (Q4 2025), and 1014382.46 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Medicure | - | - | 2.57 Mn | -296,057.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -296,057.51 |
| Dec 31, 2025 | -6.92 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -567,266.02 |
| Mar 31, 2025 | -483,660.03 |
| Dec 31, 2024 | -395,864.57 |
| Sep 30, 2024 | 489,679.68 |
| Jun 30, 2024 | -728,947.13 |
| Mar 31, 2024 | 37,847.77 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | 57,436.65 |
| Jun 30, 2023 | 286,614.20 |
| Mar 31, 2023 | 224,867.70 |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 880,991.44 |
| Jun 30, 2022 | 552,175.82 |
| Mar 31, 2022 | 380,527.14 |
| Sep 30, 2021 | -787,259.63 |
| Jun 30, 2021 | 463,710.48 |
| Mar 31, 2021 | 828,023.88 |